Company profile
Home | Harnessing the power of RNA epigenetics | Cambridge, UK | STORM Therapeutics
STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 May 2022 to 30 Apr 2023
The Covid-19 pandemic has caused unprecedented damage to global health, society and economies. The development of successful vaccines has had a major impact but the dangers of the pandemic remain due the challenges of vaccinating the whole population and that protection given by vaccination reduces over time. In addition, there remains an ongoing risk tha...
1 Feb 2019 to 31 Jan 2022
By integrating additional biomedical data, the "HumanMine" biological database system will be extended to support RNA epigenetics and cancer drug discovery.
